D1 receptor alleles predict PET metabolic correlates of clinical response to clozapine

A goal of pharmacogenetics is to clarify associations between allelic variation and risk factors in psychiatric illness. We report changes in regional brain metabolism based on dopamine alleles. Treatment-resistant schizophrenic subjects were positron emission tomography scanned with 18F-fluorodeoxy...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular psychiatry 2003, Vol.8 (1), p.109-113
Hauptverfasser: Potkin, S G, Basile, V S, Jin, Y, Masellis, M, Badri, F, Keator, D, Wu, J C, Alva, G, Carreon, D T, Bunney, W E, Fallon, J H, Kennedy, J L
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A goal of pharmacogenetics is to clarify associations between allelic variation and risk factors in psychiatric illness. We report changes in regional brain metabolism based on dopamine alleles. Treatment-resistant schizophrenic subjects were positron emission tomography scanned with 18F-fluorodeoxyglucose after 5 weeks each of placebo and clozapine treatment. Significant regional brain metabolic effects were found for the D1 receptor genotypes ( P
ISSN:1359-4184
1476-5578
DOI:10.1038/sj.mp.4001191